Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

160 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Quality of Life 5 Years Following Transfemoral TAVR or SAVR in Intermediate Risk Patients.
Kleiman NS, Van Mieghem NM, Reardon MJ, Gada H, Mumtaz M, Olsen PS, Heiser J, Merhi W, Chetcuti S, Deeb GM, Chawla A, Kiaii B, Teefy P, Chu MWA, Yakubov SJ, Windecker S, Althouse AD, Baron SJ. Kleiman NS, et al. Among authors: yakubov sj. JACC Cardiovasc Interv. 2024 Apr 22;17(8):979-988. doi: 10.1016/j.jcin.2024.02.014. JACC Cardiovasc Interv. 2024. PMID: 38658126 Clinical Trial.
2-Year Clinical and Echocardiography Follow-Up of Transcatheter Mitral Valve Replacement With the Transapical Intrepid System.
Bapat V, Weiss E, Bajwa T, Thourani VH, Yadav P, Thaden JJ, Lim DS, Reardon M, Pinney S, Adams DH, Yakubov SJ, Modine T, Redwood SR, Walton A, Spargias K, Zhang A, Mack M, Leon MB. Bapat V, et al. Among authors: yakubov sj. JACC Cardiovasc Interv. 2024 Apr 1:S1936-8798(24)00527-2. doi: 10.1016/j.jcin.2024.02.033. Online ahead of print. JACC Cardiovasc Interv. 2024. PMID: 38639690
Factors Associated With Coronary Angiography Performed Within 6 Months of Randomization to the Conservative Strategy in the ISCHEMIA Trial.
Pracoń R, Spertus JA, Broderick S, Bangalore S, Rockhold FW, Ruzyllo W, Demchenko E, Nageh T, Grossman GB, Mavromatis K, Manjunath CN, Smanio PEP, Stone GW, Mancini GBJ, Boden WE, Newman JD, Reynolds HR, Hochman JS, Maron DJ; ISCHEMIA Research Group. Pracoń R, et al. Circ Cardiovasc Interv. 2024 Apr 17:e013435. doi: 10.1161/CIRCINTERVENTIONS.123.013435. Online ahead of print. Circ Cardiovasc Interv. 2024. PMID: 38629312
Reinterventions After CoreValve/Evolut Transcatheter or Surgical Aortic Valve Replacement for Treatment of Severe Aortic Stenosis.
Grubb KJ, Lisko JC, O'Hair D, Merhi W, Forrest JK, Mahoney P, Van Mieghem NM, Windecker S, Yakubov SJ, Williams MR, Chetcuti SJ, Deeb GM, Kleiman NS, Althouse AD, Reardon MJ. Grubb KJ, et al. Among authors: yakubov sj. JACC Cardiovasc Interv. 2024 Apr 22;17(8):1007-1016. doi: 10.1016/j.jcin.2024.01.292. Epub 2024 Apr 3. JACC Cardiovasc Interv. 2024. PMID: 38573257
Pulmonary Vein Isolation With or Without Left Atrial Appendage Ligation in Atrial Fibrillation: The aMAZE Randomized Clinical Trial.
Lakkireddy DR, Wilber DJ, Mittal S, Tschopp D, Ellis CR, Rasekh A, Hounshell T, Evonich R, Chandhok S, Berger RD, Horton R, Hoskins MH, Calkins H, Yakubov SJ, Simons P, Saville BR, Lee RJ; aMAZE Investigators. Lakkireddy DR, et al. Among authors: yakubov sj. JAMA. 2024 Apr 2;331(13):1099-1108. doi: 10.1001/jama.2024.3026. JAMA. 2024. PMID: 38563835 Clinical Trial.
4-Year Outcomes of Patients With Aortic Stenosis in the Evolut Low Risk Trial.
Forrest JK, Deeb GM, Yakubov SJ, Gada H, Mumtaz MA, Ramlawi B, Bajwa T, Teirstein PS, Tchétché D, Huang J, Reardon MJ; Evolut Low Risk Trial Investigators. Forrest JK, et al. Among authors: yakubov sj. J Am Coll Cardiol. 2023 Nov 28;82(22):2163-2165. doi: 10.1016/j.jacc.2023.09.813. Epub 2023 Oct 24. J Am Coll Cardiol. 2023. PMID: 37877907 No abstract available.
160 results